This article describes a recently finalized CMS rule addressing the permissibility of co-pay accumulator adjustment programs (CAAPs) when no generic is available.
Bryan S. Walsh, JD
Advertisement
Articles by Bryan S. Walsh, JD
Advertisement
Latest Updated Articles
- CAAP Rule and Prescription Drug Prices
March 18th 2021
Advertisement
Advertisement
Trending on AJMC
1
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
2
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
3
ATTR-CM Incidence, Prevalence Rose Sharply in the US
4
Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS
5